1010 related articles for article (PubMed ID: 18424568)
1. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
3. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P
Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398
[TBL] [Abstract][Full Text] [Related]
7. Barrett's oesophagus: a clinical study of 52 patients.
Cooper BT; Barbezat GO
Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962
[TBL] [Abstract][Full Text] [Related]
8. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
[TBL] [Abstract][Full Text] [Related]
9. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
10. Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study.
Zagari RM; Law GR; Fuccio L; Pozzato P; Forman D; Bazzoli F
Am J Gastroenterol; 2010 Mar; 105(3):565-71. PubMed ID: 20010920
[TBL] [Abstract][Full Text] [Related]
11. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
12. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
[TBL] [Abstract][Full Text] [Related]
13. Review article: Barrett's oesophagus and carcinoma in Japan.
Hongo M
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
[TBL] [Abstract][Full Text] [Related]
14. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
Ortiz Escandell A; Martínez de Haro LF; Parrilla Paricio P; Molina Martínez J; Aguayo Albasini JL; Martínez Gómez D
Rev Esp Enferm Dig; 1990 Mar; 77(3):171-5. PubMed ID: 2378753
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux and related pathology in adults who were born with esophageal atresia: a long-term follow-up study.
Taylor AC; Breen KJ; Auldist A; Catto-Smith A; Clarnette T; Crameri J; Taylor R; Nagarajah S; Brady J; Stokes K
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):702-6. PubMed ID: 17544997
[TBL] [Abstract][Full Text] [Related]
16. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
[TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus: prevalence in symptomatic relatives.
Romero Y; Cameron AJ; Schaid DJ; McDonnell SK; Burgart LJ; Hardtke CL; Murray JA; Locke GR
Am J Gastroenterol; 2002 May; 97(5):1127-32. PubMed ID: 12017151
[TBL] [Abstract][Full Text] [Related]
18. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
Rosaida MS; Goh KL
Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
[TBL] [Abstract][Full Text] [Related]
19. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
20. Leptin and the risk of Barrett's oesophagus.
Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC;
Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
